| Generex Biotechnology Corporation | (OP: GNBT) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(GNBT) Community Analysis from
Bulls REASONS TO BUY
|
97%
agree
40 votes
|
Pain Free Insulin |
|
0%
agree
0 votes
|
More to Love |
|
50%
agree
2 votes
|
Massive Opportunity |
Bears REASONS TO SELL
|
100%
agree
2 votes
|
Dilluted Shares |
June 19, 2013
(Penny Stock Classroom,
7/8/11)
Stocks fell today as the economy added only 18,000 jobs in June, well below the 125,000 jobs analysts’ had expected. Job gains in May were also revised down to 25,000 from the initial...(read more)
(Benzinga,
10/11/10)
Generex Biotechnology Corporation (Nasdaq: GNBT) today announced that it has entered into a definitive agreement to acquire a majority interest (51%) in Global Medical Direct, LLC.
The closing of the transaction is subject to a number...(read more)
(Benzinga,
10/18/10)
Generex Biotechnology Corporation (Nasdaq: GNBT) announced today that Dr. Joseph Rubinfeld, an independent scientific advisor to the Company and a member of the Company's Scientific Advisory Board, issued the following statement in...(read more)
Generex Biotechnology (GNBT) Company Overview
There is no analysis for GNBT yet. But you can go to Wikinvest to help create one!
